logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Recent Advances In Nucleosides Chemistry And Chemotherapy 1st Edition Ck Chu

  • SKU: BELL-1635046
Recent Advances In Nucleosides Chemistry And Chemotherapy 1st Edition Ck Chu
$ 31.00 $ 45.00 (-31%)

4.3

28 reviews

Recent Advances In Nucleosides Chemistry And Chemotherapy 1st Edition Ck Chu instant download after payment.

Publisher: Elsevier Science
File Extension: PDF
File size: 23.69 MB
Pages: 544
Author: C.K. Chu
ISBN: 9780444509512, 0444509518
Language: English
Year: 2002
Edition: 1

Product desciption

Recent Advances In Nucleosides Chemistry And Chemotherapy 1st Edition Ck Chu by C.k. Chu 9780444509512, 0444509518 instant download after payment.

The book covers up-to-date information on nucleosides and antiviral chemotherapy contributed by the world experts in the field of nucleoside. This book is the result of a meeting honoring Dr. Jack J. Fox, who was one of the pioneers in nucleoside chemistry and chemotherapy. This book consists of 15 excellent chapters in the area, which include topics from recent synthetic methodologies, nucleoside kinase implicated in chemotherapy and drug design, excellent reviews on antiviral agents, nucleoside metabolism/mode of action in parasites, new compounds under clinical and pre-clinical trials, IMPDH inhibitors to review on nucleoside prodrugs.

Related Products